Temporomandibular Joint DisordersNCT04747743
Usage of Skeletal Muscle Relaxants Survey Among Egyptian Dental Practitioners
An observational study of Temporomandibular Joint Disorders and Bruxism, run by Future University in Egypt at 1 site in Egypt.
Trial summary
Pharmacists may also logistically serve as ideal health-care destinations to implement and deliver prevention, early intervention, and referral of oral health services to reduce the incidence of potentially preventable oral conditions including tooth decay, gum disease, and oral cancer. Read more about this study
- Who is it for?
- Ages 20 to 60 years
- Conditions the study is for
- Temporomandibular Joint Disorders, Bruxism
- What is being tested?
- a self structured questionnaire
- How many people
- 170 participants
- Where
- 1 siteEgypt
- Study dates
- 10 Feb 2021to 15 Mar 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 60 years
- All sexes
- Adult
Study population: dental practitioners in Egypt (professionals both academic and nonacademic).
Who may be able to join
- academic dental practitioners in Egypt
- nonacademic dental practitioners in Egypt
Who cannot join
- Age less than 20 or more than 60
- Non-dental
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Assessment of Dentist Pharmacist Communication About Usage of Skeletal Muscle Relaxants Survey Among Egyptian Dental Practitioners
Pharmacists may also logistically serve as ideal health-care destinations to implement and deliver prevention, early intervention, and referral of oral health services to reduce the incidence of potentially preventable oral conditions including tooth decay, gum disease, and oral cancer. Interprofessional teamwork between pharmacist and dentistry may help to encourage pharmacists to take a more active role in promoting oral health. By providing information and assistance for self-care and the use of over the counter (OTC) products for minor problems on oral health, it can provide better patient care in the Malaysian health-care system
Read the detailed description
Skeletal muscle relaxants (SMR) are a diverse group of medications that are not chemically related like other drug classes and work through a variety of mechanisms. The term "muscle relaxant" is used to refer to two major therapeutic groups: neuromuscular blockers and spasmolytic. Some of them are working mainly through the central nervous system; they have many adverse effects such as sedation and dizziness that may limit their use.
Pharmacists may also logistically serve as ideal health-care destinations to implement and deliver prevention, early intervention, and referral of oral health services to reduce the incidence of potentially preventable oral conditions including tooth decay, gum disease, and oral cancer. Interprofessional teamwork between pharmacist and dentistry may help to encourage pharmacists to take a more active role in promoting oral health. By providing information and assistance for self-care and the use of over the counter (OTC) products for minor problems on oral health, it can provide better patient care in the Malaysian health-care system
- Conditions
- Temporomandibular Joint Disorders, Bruxism
- Being tested
- a self structured questionnaire
- Medical subject headings
- Temporomandibular Joint Disorders, Bruxism
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
a self structured questionnaireOther
A self structured questionnaire to assess knowledge of skeletal muscle use in dental practice
| Study group | Role | What they receive |
|---|---|---|
| Egyptian dental practitioners | 170 dental practitioners in Egypt (professionals both academic and nonacademic). Receives: Other: a self structured questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
Dental practitioner's knowledge about muscle relaxants indications
Extent of dental practitioner's knowledge about muscle relaxants indications in practice
Measured: 1 month
importance of direct communication between dental practitioners and pharmacists in order to detect the communication barriers and how to overcome those barriers.
To assess and improve the communication between pharmacist- dentist regarding Skeletal muscle relaxant
Measured: 1 month
Secondary outcomes (2)
Dental practitioner's knowledge about muscle relaxants doses
Extent of dental practitioner's knowledge about muscle relaxants different doses in practice
Measured: 1 month
Dental practitioner's knowledge about muscle relaxants side effects
Extent of dental practitioner's knowledge about muscle relaxants possible side effects
Measured: 1 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Feb 2021
- Study start10 Feb 2021
- Primary completion10 Mar 2021
- Study completion15 Mar 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Temporomandibular Joint DisordersStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 170 participants (actual)
Sponsor and investigators
- Lead sponsor
- Future University in Egypt
- Sponsor type
- University, hospital or other
- Collaborators
- Ain Shams University, British University In Egypt, Cairo University
- Responsible party
- Principal investigator, Doaa Mohamed Salah ElDin Diab ELBohy, Future University in Egypt
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04747743
- Sponsor's protocol ID
- FUE.REC 1/1-2021
- Status last verified
- May 2022
- First submitted
- 5 Feb 2021
- Last updated
- 27 May 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 27 May 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of Dentist Pharmacist Communication About Usage of Skeletal Muscle Relaxants Survey Among Egyptian Dental Practitioners
- ClinicalTrials.gov ID
- NCT04747743
- Acronym / sponsor ID
- FUE.REC 1/1-2021
- Conditions
- Temporomandibular Joint Disorders, Bruxism
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 170 participants (actual)
- Lead sponsor
- Future University in EgyptUniversity, hospital or other
- Collaborators
- Ain Shams University, British University In Egypt, Cairo University
- Study start
- 10 Feb 2021 (actual)
- Primary completion
- 10 Mar 2021 (actual)
- Study completion
- 15 Mar 2021 (actual)
- First posted
- 10 Feb 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Pharmacists may also logistically serve as ideal health-care destinations to implement and deliver prevention, early intervention, and referral of oral health services to reduce the incidence of potentially preventable oral conditions including tooth decay, gum disease, and oral cancer. Interprofessional teamwork between pharmacist and dentistry may help to encourage pharmacists to take a more active role in promoting oral health. By providing information and assistance for self-care and the use of over the counter (OTC) products for minor problems on oral health, it can provide better patient care in the Malaysian health-care system
Detailed description
Skeletal muscle relaxants (SMR) are a diverse group of medications that are not chemically related like other drug classes and work through a variety of mechanisms. The term "muscle relaxant" is used to refer to two major therapeutic groups: neuromuscular blockers and spasmolytic. Some of them are working mainly through the central nervous system; they have many adverse effects such as sedation and dizziness that may limit their use.
Pharmacists may also logistically serve as ideal health-care destinations to implement and deliver prevention, early intervention, and referral of oral health services to reduce the incidence of potentially preventable oral conditions including tooth decay, gum disease, and oral cancer. Interprofessional teamwork between pharmacist and dentistry may help to encourage pharmacists to take a more active role in promoting oral health. By providing information and assistance for self-care and the use of over the counter (OTC) products for minor problems on oral health, it can provide better patient care in the Malaysian health-care system
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Egyptian dental practitioners | – | Other: a self structured questionnaire170 dental practitioners in Egypt (professionals both academic and nonacademic). |
Who may qualify
- Ages
- 20 to 60 years
- Sex
- All
- Age groups
- Adult
- Study population
- dental practitioners in Egypt (professionals both academic and nonacademic).
Key inclusion criteria (2 listed)
- academic dental practitioners in Egypt
- nonacademic dental practitioners in Egypt
Key exclusion criteria (2 listed)
- Age less than 20 or more than 60
- Non-dental
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| a self structured questionnaireA self structured questionnaire to assess knowledge of skeletal muscle use in dental practice | Other | Egyptian dental practitioners |
Primary outcome
Dental practitioner's knowledge about muscle relaxants indications
Time frame: 1 month
Extent of dental practitioner's knowledge about muscle relaxants indications in practice
importance of direct communication between dental practitioners and pharmacists in order to detect the communication barriers and how to overcome those barriers.
Time frame: 1 month
To assess and improve the communication between pharmacist- dentist regarding Skeletal muscle relaxant
2 secondary outcomes
Dental practitioner's knowledge about muscle relaxants doses
Time frame: 1 month
Dental practitioner's knowledge about muscle relaxants side effects
Time frame: 1 month
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 May 2022.
- Individual participant dataSharing planned: Undecided
Related trials for Temporomandibular Joint Disorders
Recruiting
Photobiomodulation for Management of Temporomandibular Disorder Pain
Pain Related to TMD
Recruiting
Effects of Vagus Nerve Stimulation on Temporomandibular Disorders.
TMD, Temporomandibular Disorders (TMDs)
Recruiting
Marine Lipids Ease Painful TMD
Temporomandibular Disorder (TMD)
Not yet recruiting
Comparing Dextrose Prolotherapy vs. Sodium Hyaluronic Acid Injections for Jaw Joint Internal Derangement
Temporomandibular Joint Internal Derangement, TMJ-ID
Recruiting
R01_Pilot Jaw Muscle Phenotypes
Chronic TMD Pain, Temporomandibular Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Temporomandibular Joint Disorders and Bruxism, run by Future University in Egypt at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 May 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Dental practitioner's knowledge about muscle relaxants indications (time frame: 1 month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 May 2022.